Got $2,000? Here Are 2 Beaten-Down Growth Stocks to Buy Right Now
You don't need a pile of cash to invest in some of today's beaten-down growth stocks. Many are trading for less than $100 a share. But if you are ready to invest a couple of thousand dollars in potential growth winners, you could pick up several shares of those particular companies and multiply your gains considerably over time. Before you jump in, though, make sure you can handle some risk and accept the idea of staying invested for a period of at least five years.
If that sounds good to you, then you might consider two biotech stocks that are on the path to launching multiple products over the next few years. That can translate into significant earnings power and potential for major share gains. These stocks are down today, offering you a great buying opportunity, but their solid pipelines mean they're not out. Let's take a look at these two struggling growth players to invest in now.
You probably know of (NASDAQ: MRNA) thanks to its blockbuster COVID-19 vaccine, its only product. But this company isn't likely to depend on the vaccine for very long. Moderna has several candidates across treatment areas in late-stage development. And the company recently said it aims to launch as many as 15 products over the coming five years.
Source Fool.com
Moderna Inc. Aktie
Die Community bevorzugt klar Moderna Inc. mit vielen Buy- und nur wenigen Sell-Einschätzungen.
Eine erhebliche Steigerung um mehr als 50% ist für Moderna Inc. mit einem Kursziel von 129 € im Vergleich zum aktuellen Kurs von 65.76 € zu erwarten.
